Dipeptidyl peptidase-IV inhibitors
US7553861B2 · kind B2 · utility
0Cited by
88References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2006 |
| Grant date | Jun 30, 2009 |
| Priority date | — |
| Expiry date | Jan 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.